0000899243-20-016500.txt : 20200615 0000899243-20-016500.hdr.sgml : 20200615 20200615161647 ACCESSION NUMBER: 0000899243-20-016500 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN MARK J CENTRAL INDEX KEY: 0001180428 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 20963471 MAIL ADDRESS: STREET 1: 29 NEWBURY STREET STREET 2: 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-11 0 0001680581 Fulcrum Therapeutics, Inc. FULC 0001180428 LEVIN MARK J C/O FULCRUM THERAPEUTICS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 0 1 0 Stock Option (right to buy) 17.63 2020-06-11 4 A 0 9285 0.00 A 2030-06-10 Common Stock 9285 9285 D This option was granted on June 11, 2020 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service. /s/ Peter Thomson, as attorney-in-fact for Mark Levin 2020-06-15